0001140361-15-014356.txt : 20150403 0001140361-15-014356.hdr.sgml : 20150403 20150403154251 ACCESSION NUMBER: 0001140361-15-014356 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150401 FILED AS OF DATE: 20150403 DATE AS OF CHANGE: 20150403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lewicki John A. CENTRAL INDEX KEY: 0001553352 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 15751225 MAIL ADDRESS: STREET 1: C/O ONCOMED PHARMACEUTICALS, INC. STREET 2: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc1.xml FORM 4 X0306 4 2015-04-01 0 0001302573 OncoMed Pharmaceuticals Inc OMED 0001553352 Lewicki John A. C/O ONCOMED PHARMACEUTICALS, INC. 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 0 1 0 0 EVP & Chief Scientific Officer Common Stock 2015-04-01 4 M 0 8500 1.43 A 29785 D Common Stock 2015-04-01 4 S 0 8500 25.1888 D 21285 D Common Stock 2015-04-02 4 M 0 8500 1.43 A 29785 D Common Stock 2015-04-02 4 S 0 6940 25.2904 D 22845 D Common Stock 2015-04-02 4 S 0 1560 25.6979 D 21285 D Common Stock 83530 I See Footnote Stock Option (Right to Buy) 1.43 2015-04-01 4 M 0 8500 0.00 A 2017-01-11 Common Stock 8500 31777 D Stock Option (Right to Buy) 1.43 2015-04-02 4 M 0 8500 0 A 2017-01-11 Common Stock 8500 23277 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2014. Includes 20,000 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit. Includes 1,285 shares acquired under the Issuer's Employee Stock Purchase Plan on February 27, 2015. This transaction was executed in multiple trades in prices ranging from $24.63 to $25.56, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. This transaction was executed in multiple trades in prices ranging from $24.62 to $25.61, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. This transaction was executed in multiple trades in prices ranging from $25.62 to $26.12, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The shares are held by John Allan Lewicki and Jenniffer Joan Lewicki, Trustees of the Lewicki Family Trust dated December 6, 2000. The option is fully vested and exercisable, subject to an annual limitation of 175,438 shares that can be issued to a single grantee upon the exercise of awards under the Issuer's 2004 Stock Incentive Plan. /s/ Alicia J. Hager, Attorney-in-Fact for John A. Lewicki 2015-04-03